Stock Detail
NATUS MEDICAL INCORPORATED
Sector: Indices SP 600
Latest Quote @ Tue May 5 07:41:13 (15 min delayed)
| $12.80 |
$15.94 |
$14.24 |
-0.12 |
-0.84% |
|
Last Day's Data
| $14.24 |
$14.66 |
$0.00 |
0.00% |
0.00 |
$14.36 |
| $14.39 |
$14.07 |
135,758.00 |
425.46M |
120,061.00 |
109.54 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 14.91 |
14.57 |
14.32 |
13.98 |
13.73 |
Stock Profile
Natus Medical Incorporated engages in the development, manufacture, and marketing of products for the detection, monitoring, treatment, and tracking of common medical disorders in newborns. The company's product line includes ALGO Newborn Hearing Screener, a product line for hearing screening; neoBLUE LED Phototherapy device, a medical device for the treatment of newborn jaundice; Neometrics line of diagnostic reagents, used for newborn metabolic screening; neonatal heat shields and oxygen delivery hoods designed to provide a stable environment of oxygen and humidity for newborns with special needs; and MiniMuffs neonatal noise attenuators, which is designed to decrease noise exposure for babies in neonatal-intensive care units. The company offers its products to hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Its sells its products through a direct sales force in the United States, through its wholly owned subsidiaries in the United Kingdom and Japan, and through distributors in 50 other countries. Natus Medical was incorporated in 1987 and is headquartered in San Carlos, California.
